T1	intervention 2 9	Dietary
T2	control 597 610	control group
T3	eligibility 390 443	BRCA mutation carriers, with or without breast cancer
T4	average-age 450 461	18‚Åª70 years
T5	eligibility 466 484	without metastases
T6	No-of-participants 818 821	213
T7	duration 859 868	six-month
T8	intervention-participants 909 912	110
T9	outcome 921 968	major changes in all the parameters under study
T10	outcome 989 1000	lost weight
T11	outcome 1014 1022	fat mass
T12	outcome 1049 1066	hip circumference
T13	outcome 1079 1092	triglycerides
T14	outcome 1108 1113	IGF-I
T15	outcome 1186 1251	levels of insulin-like growth factor-binding protein 3 (IGFI-BP3)
T16	outcome 1275 1295	IGF-I/IGFI-BP3 ratio
